C
Cirdan
Health Tech & Medtech · Lisburn, United Kingdom · Founded 2010
Leading provider of informatics software and imaging solutions that enhance and speed up the diagnosis of patients. MoreLess
Cirdan is a medical devices company focused on revolutionizing laboratories worldwide with advanced diagnostic solutions. The company offers streamlined, scalable, and automated systems that enhance clinical pathways through real-time data analysis and AI tools. Cirdan's tailored solutions cover the entire clinical pathway, optimizing patient diagnosis and boosting workflow efficiency. The company's primary product, the ULTRA Laboratory Information System (LIS), is designed to meet the needs of clinicians, scientists, pathologists, administrators, and patients. Cirdan serves a global clientele, including over 100 successful LIS installations and partnerships with 80 national laboratories. The business model revolves around providing comprehensive laboratory solutions and continuous support, ensuring expertise and assistance are always accessible. Cirdan also offers a digital pathology education platform, Cirdan Tutor, and imaging solutions for breast biopsy, surgery, and pathology. The company generates revenue through the sale and support of its diagnostic systems and educational platforms.
Talent graph
Cirdan's talent
Source: Dealroom Talent Intelligence.
Investors
7 investors on Cirdan's cap table
Sourced from Dealroom's funding and investor records.







Global footprint
Where Cirdan has talent and traffic
team presence
Market sentiment
What the market is saying about Cirdan
An AI-synthesized read of the highest-engagement posts about Cirdan on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Cirdan on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.